This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Centrose, LLC

Drug Names(s): EDC-9, EDC 9

Description: EDC-9 is an antibody-drug conjugate targeting CD20, under development by Centrose using its proprietary Extracellular Drug Conjugate (EDC) technology.

EDC9 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug